A股異動 | 國際醫學(000516.SZ)漲4.7% 公司實控人倡議全體員工增持
格隆匯9月17日丨國際醫學(000516.SZ)低位反彈漲4.69%,報10.5元,最新總市值238.9億。公司16日公吿稱,公司實際控制人劉建申倡議全體員工積極買入國際醫學股票,並承諾凡2021年9月17日至10月11日期間通過員工本人證券賬户以二級市場競價交易方式淨買入國際醫學的股票,且連續持有12個月以上並在職的員工,若因在前述時間期間內增持國際醫學股票產生的虧損,劉建申或其指定的下屬公司將以自有資金予以補償。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.